摘要
小地衣草本植物提取物被广泛用于治疗和治疗II型糖尿病。该提取物在医学上已显示出其在降低血糖和血脂水平以及降低血压方面的价值。改善肾脏功能,血脂,控制血压和心率。这些化学成分,如环烯醚类和类环烯醚苷,都存在于水溶液中。植物的乙醇提取物。Swertiamarin是一种环烯醚萜苷,是一种具有抗高血糖和抗高脂血症作用的铅化合物。急转弯与o结合Ne或更多分子靶点改变其表达和/或活性。在硅、体内和体外研究中,揭示了Swe作用的分子机制。Rtiamarin及其衍生物具有较好的抗糖尿病和抗高脂血症活性。简单地说,本文主要对swert分子靶点的解译进行了综述。亚玛琳。我们的综述将为开发治疗糖尿病和其他炎症性疾病的治疗方法和药物开辟新的途径。
关键词: 茜素、苦杏仁、半合成衍生物、抗糖尿病、抗高脂血症、2型糖尿病、胰岛素增敏剂。
图形摘要
Current Drug Targets
Title:The Molecular Targets of Swertiamarin and its Derivatives Confer Anti- Diabetic and Anti-Hyperlipidemic Effects
Volume: 19 Issue: 16
关键词: 茜素、苦杏仁、半合成衍生物、抗糖尿病、抗高脂血症、2型糖尿病、胰岛素增敏剂。
摘要: The herbal plant extract of Enicostemma littorale is widely used to medicate and treat type II Diabetes. This extract in medicine has shown its value in reducing blood glucose & lipid levels, and improving the kidney functioning, lipid profile, controlling blood pressure and heart rate. The well characterized chemical components such as iridoid and secoiridoid glycosides are present in aqueous and ethanolic extracts of the plant. Swertiamarin, a secoiridoid glycoside, is identified as the lead compound that confers anti-hyperglycemic & anti-hyperlipidemic effects. The swertiamarin binds with one or more molecular targets to alter their expression and/or activity. The in silico, in vivo and in vitro studies have been carried out to uncover the underlying molecular mechanism of action of swertiamarin and its derivatives for showing the better anti-diabetic & anti-hyperlipidemic activities. In brief, the present review focuses on unraveling the information about molecular targets of swertiamarin. Our review will open new avenues to develop therapeutic approaches and drugs to treat diabetes and other inflammatory diseases.
Export Options
About this article
Cite this article as:
The Molecular Targets of Swertiamarin and its Derivatives Confer Anti- Diabetic and Anti-Hyperlipidemic Effects, Current Drug Targets 2018; 19 (16) . https://dx.doi.org/10.2174/1389450119666180406113428
DOI https://dx.doi.org/10.2174/1389450119666180406113428 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diabetes in Racial and Ethnic Minorities in the United States: Individualizing Approaches to Diagnosis and Management
Current Diabetes Reviews Isolated Compounds from Natural Products with Potential Antidiabetic Activity - A Systematic Review
Current Diabetes Reviews Clinical Significance of Umami Taste and Umami-Related Gene Expression Analysis for the Objective Assessment of Umami Taste Loss
Current Pharmaceutical Design Use of New Therapeutic Compounds in Pregnancy with Renal Disease
Current Women`s Health Reviews Radiological Presentation of H1N1 Influenza in the 2017 Outbreak in India and Correlation with Patient Outcome
Current Respiratory Medicine Reviews Live Yeast Cell Derivative Induces c-fos Expression in THP-1 Monocytes
Medicinal Chemistry Regulation of the DNA Damage Response to DSBs by Post-Translational Modifications
Current Genomics Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics
Current HIV Research Role of microRNAs in Non-Alcoholic Steatohepatitis
Current Pharmaceutical Design Development and Evaluation of Nateglinide Loaded Polycaprolactone Nanoparticles
Micro and Nanosystems A Review on Molecular Mechanisms and Patents of Marine-derived Anti-thrombotic Agents
Current Drug Targets Molecular and Pathophysiological Mechanisms of Diabetic Retinopathy in Relation to Adhesion Molecules
Current Diabetes Reviews Targeting MCP-1 to Reduce Vascular Complications of Obesity
Recent Patents on Cardiovascular Drug Discovery Intravitreal Injections and Diabetic Macular Edema: Actual and New Therapeutic Options
Current Diabetes Reviews Patient Centered Studies Focusing on Diabetes Self-Management: A Scoping Review
Current Diabetes Reviews Sodium-glucose Cotransporter 2 Inhibitors: The Pleiotropic Mechanisms of Actions
Cardiovascular & Hematological Disorders-Drug Targets Stroke and Hypertension: An Appraisal from Pathophysiology to Clinical Practice
Current Vascular Pharmacology The Management of Phosphodiesterase-5 (PDE5) Inhibitor Failure
Current Vascular Pharmacology HLA-G - From Fetal Tolerance to a Regulatory Molecule in Inflammatory Diseases
Current Immunology Reviews (Discontinued) Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery
Current Cancer Drug Targets